| Value | ₹212.0 Cr |
|---|---|
| Execution period | By the end of FY 2027-28 |
BSE filing, NSE: ACUTAAS. Summary written from the filing by ALFA Finder's alert engine.
Acutaas Chemicals Ltd: key numbers
- Share price
- ₹4,005.10
- Market cap
- ₹32,790 Cr
- Revenue (annual)
- ₹1,339 Cr
- Net profit (annual)
- ₹356.3 Cr
- P/E (TTM)
- 74.7×Sector 46.1×
- Promoter holding
- 32.66%+0.00% QoQ
- FII holding
- 22.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Acutaas Chemicals Ltd
All →Acutaas Chemicals Earnings Call Transcript: Key Takeaways
Acutaas reports high-growth Q2 fueled by pharma intermediates and CDMO scaling, despite commodity chemical phase-outs.
- Call
- Guides 100% growth
Acutaas Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹4,369 Mn (+42.7% YoY), EBITDA ₹1,760 Mn (+84.6%, 40.3% margin), PAT ₹1,231 Mn (+71.4%). FY27 revenue guidance raised; South Korea semiconductor-chemicals facility inaugurated.
- Call
- Guides 30% growth
Acutaas Chemicals Results Update
Q2 FY27 revenue rose 42.7% YoY to ₹4,369 mn; PAT up 71.4% to ₹1,231 mn. Guidance raised to 30% revenue growth and 38-40% EBITDA margin.
Acutaas Chemicals Q2 FY27 Results: Net Profit ₹123.1 Cr, Up 71.2% YoY
Acutaas Chemicals Ltd reported revenue from operations of ₹436.9 Cr (+42.7% YoY) and net profit of ₹123.1 Cr (+71.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹123.1 Cr · +71.2% YoY
Acutaas Chemicals Financial Results
Acutaas Chemicals' board approved Q2 and half-year FY2027 unaudited results. The board meeting closed with no other material transaction disclosed.
Acutaas Chemicals Board Meeting Date
Acutaas Chemicals scheduled its board meeting for October 27, 2026, to approve Q2 and H1 FY27 unaudited results. No financial figures or decisions are reported, only the meeting date and agenda.
Other capacity expansion announcements
All →Ashiana Housing Capacity Expansion
Ashiana Housing signed a JDA for a Senior Living project on 4.41 acres in Gurugram. The 7.25 lakh sq. ft. area has estimated ₹1,300 Crore sales potential.
- saleable area of Senior Living project
- 725000 sq. ft.
Schneider Electric Infrastructure Capacity Expansion: ₹211 Cr Investment
Schneider Electric Infrastructure's board approved ₹211 Crore to expand KMVC facility capacity to 375,000 Vacuum Interrupters and add 18,000 Breakers per annum by FY 2028-29.
- Value
- ₹211.0 Cr
- Execution
- by end of FY 2028-29
- Vacuum Interrupter capacity at KMVC
- 375000 units per annum
KK Shah Hospitals Capacity Expansion
KK Shah Hospitals has commenced commercial operations of its 1.5T Siemens MRI scanner. This strengthens the company's diagnostic imaging infrastructure.
Senores Pharmaceuticals Capacity Expansion: ₹43 Cr Investment
Senores Pharmaceuticals disclosed capacity expansion at three subsidiaries with total estimated cost of ₹43 Crore. Expansions adding ~1.5 Bn units/annum are expected by March 2027.
- Value
- ₹43.00 Cr
- Execution
- By end of March 2027
- manufacturing capacity addition (per annum)
- 1502.7 Mn units
Speciality Restaurants Capacity Expansion
Speciality Restaurants launched a new restaurant named WALTERS in Malad West, Mumbai, on October 28, 2026. The filing is a Reg 30 disclosure of a domestic restaurant launch with no monetary value stated.
- new restaurant outlets
- outlets
Goodluck India Capacity Expansion: ₹80 Cr Investment
Goodluck India's subsidiary Goodluck Defence and Aerospace approved adding Aerospace Components as a new line of business. The estimated investment is Rs 80 Crore, within a previously approved capital outlay.
- Value
- ₹80.00 Cr